DFTX · NASDAQ · Biotechnology

Definium Therapeutics (DFTX)

Develops lysergide and R(-)-MDMA drug candidates for anxiety, depression and autism.

$40.00
After hours−0.33 (−0.82%)
At close$40.33(+2.67%)